Merit Medical Systems, Inc. Stock

Equities

MMSI

US5898891040

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq 16:00:00 2024-04-26 EDT 5-day change 1st Jan Change
73.78 USD +0.55% Intraday chart for Merit Medical Systems, Inc. +2.43% -2.87%
Sales 2024 * 1.32B 1.8B Sales 2025 * 1.39B 1.9B Capitalization 4.27B 5.84B
Net income 2024 * 129M 176M Net income 2025 * 152M 208M EV / Sales 2024 * 3.33 x
Net Debt 2024 * 120M 164M Net cash position 2025 * 47M 64.24M EV / Sales 2025 * 3.04 x
P/E ratio 2024 *
33.8 x
P/E ratio 2025 *
28.8 x
Employees 6,950
Yield 2024 *
-
Yield 2025 *
-
Free-Float 97.56%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.55%
1 week+2.43%
Current month-2.60%
1 month+1.19%
3 months-5.56%
6 months+16.21%
Current year-2.87%
More quotes
1 week
71.57
Extreme 71.57
75.04
1 month
70.70
Extreme 70.7
76.37
Current year
70.70
Extreme 70.7
81.99
1 year
62.58
Extreme 62.58
85.62
3 years
50.46
Extreme 50.46
85.62
5 years
19.50
Extreme 19.5
85.62
10 years
11.41
Extreme 11.41
85.62
More quotes
Managers TitleAgeSince
Chief Executive Officer 74 87-06-30
Director of Finance/CFO 46 09-11-30
Chief Operating Officer 58 -
Members of the board TitleAgeSince
Chief Executive Officer 74 87-06-30
Director/Board Member 60 22-04-30
Director/Board Member 63 20-06-21
More insiders
Date Price Change Volume
24-04-26 73.78 +0.55% 283,441
24-04-25 73.38 -0.88% 341,471
24-04-24 74.03 -0.20% 248,079
24-04-23 74.18 +1.27% 381,140
24-04-22 73.25 +1.69% 289,012

Delayed Quote Nasdaq, April 26, 2024 at 04:00 pm

More quotes
Merit Medical Systems, Inc. designs, develops, manufactures, markets and sells medical products for interventional and diagnostic procedures. The Company is engaged in the development, manufacture and distribution of proprietary disposable medical devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy. Its cardiovascular segment consists of four product categories: peripheral intervention, cardiac intervention, custom procedural solutions and original equipment manufacturer. Within these product categories, it sells a variety of products, including cardiology and radiology devices, as well as embolotherapeutic, cardiac rhythm management, electrophysiology, critical care and others. Its endoscopy segment consists of gastroenterology and pulmonology devices which assist in the palliative treatment of expanding esophageal, tracheobronchial and biliary strictures caused by malignant tumors.
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
11
Last Close Price
73.78 USD
Average target price
93.05 USD
Spread / Average Target
+26.12%
Consensus